Newsstand
Pharmaceuticals and Healthcare Reports China Dyslipidemia Market Click to read
  • Comments

Pharmaceuticals and Healthcare Reports

China Dyslipidemia Market

Published on in “Health & Fitness, Health & Fitness”, language — English. 3 pages.
More so than in any other market, the statins dominated Chinese dyslipidemia drugs sales in the 2013 base year, contributing 84% to the total market share, reflecting sales of $1.7 billion in total sales More
Download
Subscribe for FREE

Other publications of “Pharmaceuticals and Healthcare Reports”

View all publications

Related Magazines